Bruce C. Cozadd

2014

In 2014, Bruce C. Cozadd earned a total compensation of $11.6M as Chairman and CEO at Jazz Pharmaceuticals, a 40% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$1,020,900
Option Awards$4,194,452
Salary$830,000
Stock Awards$5,498,457
Other$11,692
Total$11,555,501

Cozadd received $5.5M in stock awards, accounting for 48% of the total pay in 2014.

Cozadd also received $1M in non-equity incentive plan, $4.2M in option awards, $830K in salary and $11.7K in other compensation.

Rankings

In 2014, Bruce C. Cozadd's compensation ranked 397th out of 13,032 executives tracked by ExecPay. In other words, Cozadd earned more than 97.0% of executives.

ClassificationRankingPercentile
All
397
out of 13,032
97th
Division
Manufacturing
143
out of 4,966
97th
Major group
Chemicals And Allied Products
46
out of 1,686
97th
Industry group
Drugs
36
out of 1,365
97th
Industry
Pharmaceutical Preparations
34
out of 1,043
97th
Source: SEC filing on June 20, 2017.

Cozadd's colleagues

We found five more compensation records of executives who worked with Bruce C. Cozadd at Jazz Pharmaceuticals in 2014.

2014

Russell Cox

Jazz Pharmaceuticals

Chief Operating Officer

2014

Suzanne Hooper

Jazz Pharmaceuticals

Executive Vice President and GC

2014

Matthew Young

Jazz Pharmaceuticals

Chief Financial Officer

2014

Michael Miller

Jazz Pharmaceuticals

Senior Vice President, U.S. Commercial

2014

Kathryn Falberg

Jazz Pharmaceuticals

Chief Financial Officer

News

You may also like